Antibiotics for community-acquired pneumonia in adult outpatients

Added October 25, 2013

Read the full review here

There is insufficient evidence from randomised controlled trials (RCTs) on the efficacy of various antibiotic treatments in patients who are older than 12 years of age with a diagnosis of  community acquired pneumonia (CAP).

CAP is associated with very high mortality and morbidity rates, particularly in the elderly population. Antibiotic treatment is one of the most common methods of treatment for CAP although it is often associated with increased antibacterial resistance and adverse effects. The aim of this review was to summarise all available evidence from RCTs on the efficacy of various antibacterial treatments for CAP in participants older than 12 years.